Skip to content
Search

Latest Stories

BAME groups face 'two to three times' higher risk of dying, says study

THE risk of dying from coronavirus is two to three times higher for England's black and minority ethnic communities, according to an academic analysis of health service data reported Thursday.

The study, by University College London (UCL), is the latest to suggest that the Covid-19 illness hits ethnic minorities in Britain and other Western countries disproportionately hard.


UCL researchers mined data from the state-run National Health Service (NHS) of patients who had tested positive for the virus and died in hospitals in England from March 1 to April 21.

They found the average risk of death was "around two to three times higher" for black, Asian and other ethnic minority groups when compared to the general population.

The risk of death for people of Pakistani heritage was 3.29 times higher, for a black African background it was 3.24 times higher and 2.41 times higher for Bangladeshi.

Black Caribbean communities were 2.21 times more at risk, and Indian groups 1.7 times.

In contrast the researchers, who analysed 16,272 deaths from the virus in the study period -- though ethnicity was missing in nearly 10 percent of cases -- discovered a lower fatality risk for white populations in England.

"Rather than being an equaliser, this work shows that mortality with Covid-19 is disproportionately higher in black, Asian and minority ethnic groups," said UCL's Delan Devakumar, the study's co-author.

"It is essential to tackle the underlying social and economic risk factors and barriers to healthcare that lead to these unjust deaths."

The analysis, which is awaiting peer review, follows other recent British studies showing people in disadvantaged areas -- typically more heavily populated by ethnic minorities -- had been worse hit by the virus.

A recent assessment by the Institute for Fiscal Studies noted similarly higher hospital fatality rates for those from ethnic minority backgrounds than white British communities.

ONS DATA

Black people and those of Indian, Bangladeshi and Pakistani ethnicity have a "significantly higher" chance of dying from Covid-19 than White people, the Office for National Statistics said on Thursday.

"Black males are 4.2 times more likely to die from a Covid-19-related death and Black females are 4.3 times more likely than White ethnicity males and females," the ONS added.

"People of Bangladeshi and Pakistani, Indian, and mixed ethnicities also had statistically significant raised risk of death involving Covid-19 compared with those of White ethnicity."

Males of Bangladeshi and Pakistani ethnicity were 1.8 times more likely to die, according to an assessment.

Scientists cautioned that there were vast holes in their knowledge and cite striking differences in the death rates based on age, sex and ethnicity.

Genetics, they say, might hold many clues that could help eventually reveal a path to medicines or a vaccine that could treat the disease.

Earlier, figures from the ONS had found Covid-19 mortality rate in the most disadvantaged areas of England was 118 per cent higher than in more well-off locations.

More For You

The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Sinha’s message was one of resilience and realism

Getty

The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Paul Sinha, known to viewers of ITV’s The Chase as “The Sinnerman,” has spoken candidly about his experience living with Parkinson’s disease. During an appearance on Loose Women on Thursday, 17 April, the comedian and quizzer reflected on his journey from diagnosis to managing the condition day to day.

Sinha, who was diagnosed with the progressive neurological disorder in 2019, revealed that his earliest symptoms were not what many would typically associate with Parkinson’s.

Keep ReadingShow less
Toblerone dark chocolate discontinued in the UK, confirms Mondelez

This reflects both the popularity of the product and the frustration of fans

iStock

Toblerone dark chocolate discontinued in the UK, confirms Mondelez

Toblerone fans in the UK will no longer be able to purchase the dark chocolate version of the iconic Swiss chocolate bar, as manufacturer Mondelez has confirmed it has discontinued the product.

The company stated that it has made the “difficult decision” to stop production of the 360g Toblerone Dark bar. While no specific reason was given, Mondelez acknowledged the disappointment it may cause among consumers. A spokesperson said: “While we understand that this may be disappointing for some consumers, we continue to invest in Toblerone.”

Keep ReadingShow less
Crispello Comeback: Cadbury’s Light Treat Hits B&M Shelves

The return to UK shelves has brought a wave of nostalgia for many

Getty

Cadbury Crispello chocolate bars return to UK shelves at B&M for 49p

Cadbury's Crispello chocolate bars have made a surprise return to UK stores, now available at B&M for just 49p. The product, a mix of light wafer and smooth chocolate, had previously been discontinued in the UK and was only available overseas in recent years.

Each individual pack of Crispello contains four chocolate-covered wafer fingers, filled with a creamy chocolate centre. The sweet treat has gained attention on social media, with shoppers expressing their excitement about its reappearance in British stores.

Keep ReadingShow less
 Sharon Osbourne

Celebrities including Sharon Osbourne and Oprah Winfrey might be exhibiting signs of this side effect

Instagram/ Sharonosbourne

‘Ozempic feet’ joins growing list of unusual side effects linked to popular weight-loss drug

Ozempic, the blockbuster weight-loss medication that has surged in popularity across the United States and among celebrities, is now being linked to a new and unexpected side effect like sagging skin on the feet, informally dubbed “Ozempic feet”.

Medical experts say the condition is caused by rapid fat loss, which not only alters the appearance of the face and buttocks, but can also lead to aesthetic changes in the feet. As the drug continues to make headlines for its weight-loss benefits, concerns about such side effects are also gaining attention.

Keep ReadingShow less